{"pmid":32344452,"title":"Rapid detection of SARS-CoV-2 in saliva: Can an endodontist take the lead in point-of-care COVID-19 testing?","text":["Rapid detection of SARS-CoV-2 in saliva: Can an endodontist take the lead in point-of-care COVID-19 testing?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious zoonotic virus that originated from Wuhan, China, in December 2019. The resulting disease known as COVID-19 was declared as a pandemic by WHO on March 11, 2020. As of April 25, 2020, more than 2.72 million cases have been reported across 213 countries and territories, resulting in more than 187,847 deaths (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). The disease spreads through aerosol droplets and has an incubation period of 1-14 days. Research addressing crucial unknowns regarding clinical severity, the extent of transmission, and treatment options is going on all over the world since the disease inception. The primary response strategy includes limiting human-to-human transmission.","Int Endod J","Sharma, Sidhartha","Kumar, Vijay","Chawla, Amrita","Logani, Ajay","32344452"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious zoonotic virus that originated from Wuhan, China, in December 2019. The resulting disease known as COVID-19 was declared as a pandemic by WHO on March 11, 2020. As of April 25, 2020, more than 2.72 million cases have been reported across 213 countries and territories, resulting in more than 187,847 deaths (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). The disease spreads through aerosol droplets and has an incubation period of 1-14 days. Research addressing crucial unknowns regarding clinical severity, the extent of transmission, and treatment options is going on all over the world since the disease inception. The primary response strategy includes limiting human-to-human transmission."],"journal":"Int Endod J","authors":["Sharma, Sidhartha","Kumar, Vijay","Chawla, Amrita","Logani, Ajay"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344452","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/iej.13317","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1665351883820105728,"score":8.574329,"similar":[{"pmid":32311181,"title":"SARS-CoV-2: What Can Saliva Tell Us?","text":["SARS-CoV-2: What Can Saliva Tell Us?","An epidemic pneumonia was first reported in the city of Wuhan, China, in the end of December 2019, had its aetiological agent identified as a new coronavirus (Zhu et al., 2020). The World Health Organisation (WHO) declared on 11 March 2020 that the epidemic of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic now called COVID-19.","Oral Dis","Braz-Silva, Paulo Henrique","Pallos, Debora","Giannecchini, Simone","To, Kelvin Kai-Wang","32311181"],"abstract":["An epidemic pneumonia was first reported in the city of Wuhan, China, in the end of December 2019, had its aetiological agent identified as a new coronavirus (Zhu et al., 2020). The World Health Organisation (WHO) declared on 11 March 2020 that the epidemic of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic now called COVID-19."],"journal":"Oral Dis","authors":["Braz-Silva, Paulo Henrique","Pallos, Debora","Giannecchini, Simone","To, Kelvin Kai-Wang"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311181","week":"202017|Apr 20 - Apr 26","doi":"10.1111/odi.13365","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664632501317926912,"score":202.66986},{"pmid":32292802,"pmcid":"PMC7138902","title":"Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","text":["Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.","Virusdisease","Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama","32292802"],"abstract":["Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus."],"journal":"Virusdisease","authors":["Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292802","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s13337-020-00575-1","keywords":["covid-19","china","emergence","global transmission","sars-cov-2","wuhan city"],"source":"PubMed","topics":["Prevention","Transmission","Treatment","Diagnosis"],"weight":1,"locations":["Wuhan","Hubei","China","Wuhan","China","Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636192484753408,"score":197.22134},{"pmid":32341630,"pmcid":"PMC7179067","title":"Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","text":["Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing.","Indian J Occup Environ Med","Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby","32341630"],"abstract":["Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing."],"journal":"Indian J Occup Environ Med","authors":["Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341630","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4103/ijoem.IJOEM_49_20","keywords":["containment","sars-cov 2","prevention","travel","workplace"],"locations":["Coronaviruses","Wuhan","China","Workplaces"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1665351883891408896,"score":191.47456},{"pmid":32235575,"title":"The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.","text":["The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.","The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) outbreak has engulfed an unprepared world amidst a festive season. The zoonotic SARS-CoV-2, believed to have originated from infected bats, is the seventh member of enveloped RNA coronavirus. Specifically, the overall genome sequence of the SARS-CoV-2 is 96.2% identical to that of bat coronavirus termed BatCoV RaTG13. Although the current mortality rate of 2% is significantly lower than that of SARS (9.6%) and Middle East respiratory syndrome (MERS) (35%), SARS-CoV-2 is highly contagious and transmissible from human to human with an incubation period of up to 24 days. Some statistical studies have shown that, on average, one infected patient may lead to a subsequent 5.7 confirmed cases. Since the first reported case of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 on December 1, 2019, in Wuhan, China, there has been a total of 60,412 confirmed cases with 1370 fatalities reported in 25 different countries as of February 13, 2020. The outbreak has led to severe impacts on social health and the economy at various levels. This paper is a review of the significant, continuous global effort that was made to respond to the outbreak in the first 75 days. Although no vaccines have been discovered yet, a series of containment measures have been implemented by various governments, especially in China, in the effort to prevent further outbreak, whilst various medical treatment approaches have been used to successfully treat infected patients. On the basis of current studies, it would appear that the combined antiviral treatment has shown the highest success rate. This review aims to critically summarize the most recent advances in understanding the coronavirus, as well as the strategies in prevention and treatment.","Int J Environ Res Public Health","Yan, Yuxin","Shin, Woo In","Pang, Yoong Xin","Meng, Yang","Lai, Jianchen","You, Chong","Zhao, Haitao","Lester, Edward","Wu, Tao","Pang, Cheng Heng","32235575"],"abstract":["The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) outbreak has engulfed an unprepared world amidst a festive season. The zoonotic SARS-CoV-2, believed to have originated from infected bats, is the seventh member of enveloped RNA coronavirus. Specifically, the overall genome sequence of the SARS-CoV-2 is 96.2% identical to that of bat coronavirus termed BatCoV RaTG13. Although the current mortality rate of 2% is significantly lower than that of SARS (9.6%) and Middle East respiratory syndrome (MERS) (35%), SARS-CoV-2 is highly contagious and transmissible from human to human with an incubation period of up to 24 days. Some statistical studies have shown that, on average, one infected patient may lead to a subsequent 5.7 confirmed cases. Since the first reported case of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 on December 1, 2019, in Wuhan, China, there has been a total of 60,412 confirmed cases with 1370 fatalities reported in 25 different countries as of February 13, 2020. The outbreak has led to severe impacts on social health and the economy at various levels. This paper is a review of the significant, continuous global effort that was made to respond to the outbreak in the first 75 days. Although no vaccines have been discovered yet, a series of containment measures have been implemented by various governments, especially in China, in the effort to prevent further outbreak, whilst various medical treatment approaches have been used to successfully treat infected patients. On the basis of current studies, it would appear that the combined antiviral treatment has shown the highest success rate. This review aims to critically summarize the most recent advances in understanding the coronavirus, as well as the strategies in prevention and treatment."],"journal":"Int J Environ Res Public Health","authors":["Yan, Yuxin","Shin, Woo In","Pang, Yoong Xin","Meng, Yang","Lai, Jianchen","You, Chong","Zhao, Haitao","Lester, Edward","Wu, Tao","Pang, Cheng Heng"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235575","week":"202014|Mar 30 - Apr 05","doi":"10.3390/ijerph17072323","keywords":["covid-19","sars-cov-2","coronavirus","coronavirus-infected pneumonia","novel coronavirus pneumonia","zoonotic pathogen"],"source":"PubMed","topics":["Mechanism","Prevention","Treatment"],"weight":1,"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638354112643072,"score":187.48485},{"pmid":32336243,"title":"Anesthesia and COVID-19: What We Should Know and What We Should Do.","text":["Anesthesia and COVID-19: What We Should Know and What We Should Do.","Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), was first reported in Wuhan, Hubei, China, and has spread to more than 200 other countries around the world. COVID-19 is a highly contagious disease with continuous human-to-human transmission. The origin of the virus is unknown. Airway manipulations and intubations, which are common during anesthesia procedures may increasingly expose anesthesia providers and intensive care unit team members to SARS-CoV-2. Through a comprehensive review of existing studies on COVID-19, this article presents the epidemiological and clinical characteristics of COVID-19, reviews current medical management, and suggests ways to improve the safety of anesthetic procedures. Owing to the highly contagious nature of the virus and the lack of therapeutic drugs or vaccines, precautions should be taken to prevent medical staff from COVID-19.","Semin Cardiothorac Vasc Anesth","Tang, Linda Y","Wang, Jingping","32336243"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), was first reported in Wuhan, Hubei, China, and has spread to more than 200 other countries around the world. COVID-19 is a highly contagious disease with continuous human-to-human transmission. The origin of the virus is unknown. Airway manipulations and intubations, which are common during anesthesia procedures may increasingly expose anesthesia providers and intensive care unit team members to SARS-CoV-2. Through a comprehensive review of existing studies on COVID-19, this article presents the epidemiological and clinical characteristics of COVID-19, reviews current medical management, and suggests ways to improve the safety of anesthetic procedures. Owing to the highly contagious nature of the virus and the lack of therapeutic drugs or vaccines, precautions should be taken to prevent medical staff from COVID-19."],"journal":"Semin Cardiothorac Vasc Anesth","authors":["Tang, Linda Y","Wang, Jingping"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336243","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/1089253220921590","keywords":["covid-19","mers","ppe","rt-pcr test","sars-cov-2","anesthesia","coronavirus","epidemiology","pandemic","pneumonia"],"locations":["Wuhan","Hubei","China","Anesthesia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention","Treatment"],"weight":1,"_version_":1665264685444759552,"score":167.23065}]}